Scarica l'app Stockscreener
3.58
1.13%
0.04
Dopo l'orario di chiusura:
3.75
0.17
+4.75%
Scpharmaceuticals Inc Borsa (SCPH) Ultime notizie
Wearable Injector Market Is Booming So Rapidly 2025-2032 - openPR.com
BNP Paribas Financial Markets Increases Stake in scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
Shareholders Will Likely Find scPharmaceuticals Inc.'s (NASDAQ:SCPH) CEO Compensation Acceptable - simplywall.st
Captrust Financial Advisors Acquires 21,523 Shares of scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
scPharmaceuticals: Furoscix Sales To Accelerate Throughout 2025 - Seeking Alpha
Price T Rowe Associates Inc. MD Buys Shares of 15,143 scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
scPharmaceuticals Inc. (NASDAQ:SCPH) Shares Purchased by Comerica Bank - Defense World
Leerink Partnrs Analysts Lower Earnings Estimates for SCPH - Defense World
What is HC Wainwright’s Estimate for SCPH Q1 Earnings? - Defense World
What is Leerink Partnrs’ Forecast for SCPH FY2027 Earnings? - Defense World
scPharmaceuticals Inc. (NASDAQ:SCPH) Q1 2025 Earnings Call Transcript - Insider Monkey
Market Sentiment Around Loss-Making scPharmaceuticals Inc. (NASDAQ:SCPH) - simplywall.st
scPharmaceuticals First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
scPharmaceuticals Earnings Call Highlights Growth and Expansion - TipRanks
ScPharmaceuticals targets CKD launch and rising Medicare fill rates to accelerate FUROSCIX growth trajectory - MSN
ScPharmaceuticals, Inc. (SCPH) Reports Q1 Loss, Misses Revenue Estimates - MSN
ScPharmaceuticals Doubles FUROSCIX Sales In Q1, Launches In CKD, Eyes Autoinjector Filing In Q3 - Nasdaq
scPharmaceuticals Inc (SCPH) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Expansion - Yahoo
scPharmaceuticals Inc (SCPH) Q1 2025 Earnings Call Highlights: R - GuruFocus
scPharmaceuticals Reports Strong Q1 2025 Growth - TipRanks
SCPH Reports Revenue Growth and Positive Outlook for FUROSCIX | - GuruFocus
Earnings call transcript: SC Pharmaceuticals Q1 2025 results miss forecast By Investing.com - Investing.com South Africa
Earnings call transcript: SC Pharmaceuticals Q1 2025 results miss forecast - Investing.com
scPharmaceuticals Inc Reports Q1 2025 Revenue of $11.8 Million, Exceeding Estimates; EPS Details Not Provided - GuruFocus
scPharmaceuticals Inc reports results for the quarter ended March 31Earnings Summary - TradingView
SCPH Reports Revenue Growth and Positive Outlook for FUROSCIX | SCPH Stock News - GuruFocus
scPharmaceuticals Inc. Reports First Quarter 2025 Financial Results and Provides Business Update - The Manila Times
Wells Fargo & Company MN Purchases 9,663 Shares of scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
Insights Ahead: scPharmaceuticals's Quarterly Earnings - Nasdaq
scPharmaceuticals Inc (SCPH) Q1 2025: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
scPharmaceuticals Inc (SCPH) Q1 2025: Everything You Need To Kno - GuruFocus
Barclays PLC Buys 24,717 Shares of scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
scPharmaceuticals (SCPH) Expected to Announce Earnings on Tuesday - Defense World
89,690 Shares in scPharmaceuticals Inc. (NASDAQ:SCPH) Bought by Raymond James Financial Inc. - Defense World
scPharmaceuticals to Announce First Quarter 2025 Financial Results After the Market Close on May 14, 2025 - The Manila Times
Invesco Ltd. Purchases 6,073 Shares of scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
JPMorgan Chase & Co. Raises Position in scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
scPharmaceuticals Announces Participation in Three Upcoming Investor Conferences - The Manila Times
scPharmaceuticals Expands Investor Outreach: CEO Set for Citizens, Craig-Hallum, and Wainwright Conferences - Stock Titan
Geode Capital Management LLC Boosts Holdings in scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
Stock Market Recap: scPharmaceuticals Inc (SCPH) Concludes at 2.63, a -5.23 Surge/Decline - DWinneX
Purple Biotech (NASDAQ:PPBT) versus scPharmaceuticals (NASDAQ:SCPH) Financial Review - Defense World
Corebridge Financial Inc. Raises Holdings in scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
Raymond James Financial Inc. Makes New $318,000 Investment in scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
Raymond James Financial Inc. Invests $318,000 in scPharmaceuticals Inc. (NASDAQ:SCPH) - The AM Reporter
SCPH stock touches 52-week low at $2.19 amid market challenges - Investing.com
U.S. FDA approves ScPharmaceuticals' heart failure therapy - MarketScreener
Market Cool On scPharmaceuticals Inc.'s (NASDAQ:SCPH) Revenues Pushing Shares 30% Lower - simplywall.st
Charles Schwab Investment Management Inc. Acquires 26,964 Shares of scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
Bank of New York Mellon Corp Raises Stock Position in scPharmaceuticals Inc. (NASDAQ:SCPH) - Defense World
scPharmaceuticals stock hits 52-week low at $2.73 By Investing.com - Investing.com South Africa
8.70%
1.64%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):